Cidara Provides Corporate Update and Reports First Quarter 2018 Financial Results
10 mai 2018 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206
25 janv. 2018 09h00 HE
|
Novan, Inc.
MORRISVILLE, N.C., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that the first patient has been dosed in the Company's Phase 2 clinical...
Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update
01 nov. 2017 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will...
Assembly Biosciences Announces 2017 AASLD Presentations
02 oct. 2017 07h00 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development
25 sept. 2017 07h00 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations
16 févr. 2017 07h05 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting
11 nov. 2016 08h00 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Nov. 11, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
18 nov. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Peregrine Pharmaceuticals, Inc.
17 mai 2010 08h30 HE
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwire - May 17, 2010) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Peregrine...
Borealis Discloses Technology for New Medical, Sensor, Chemical and Industrial Uses
08 févr. 2010 16h49 HE
|
Borealis Exploration Limited
GIBRALTAR--(Marketwire - February 8, 2010) - Borealis Exploration Limited (PINKSHEETS: BOREF)
has received a U.S. patent for its Avto Metals Technology covering multiple
applications in several...